BD Pharmingen- PE Mouse IgG2b- - Isotype Control_BD Pharmingen
参考图片
Expression of human IL-8 by stimulated CD14+ human monocytes. Human PBMC were stimulated for 6 hours with LPS (1.0 µg/ml final concentration) in the presence of GolgiStop™ (2 µM final concentration; Cat. No. 554724). The PBMC were harvested, stained with 0.25 µg of FITC-mouse anti-human CD14 monoclonal antibody (FITC-M5E2, Cat. No. 555397), fixed, permeabilized, and subsequently stained with either 0.125 µg of PE-anti-human IL-8 (Cat. No. 554720; left panel), or 0.125 µg of PE-mouse IgG2b (Cat. No. 555058; middle panel), following BD PharMingen staining protocol. The data reflect gating on monocytes, based on forward and side scattered light signals. The quadrant markers for the bivariate dot plot were set based on autofluorescence controls (right panel).
Expression of human IL-8 by stimulated CD14+ human monocytes. Human PBMC were stimulated for 6 hours with LPS (1.0 µg/ml final concentration) in the presence of GolgiStop™ (2 µM final concentration; Cat. No. 554724). The PBMC were harvested, stained with 0.25 µg of FITC-mouse anti-human CD14 monoclonal antibody (FITC-M5E2, Cat. No. 555397), fixed, permeabilized, and subsequently stained with either 0.125 µg of PE-anti-human IL-8 (Cat. No. 554720; left panel), or 0.125 µg of PE-mouse IgG2b (Cat. No. 555058; middle panel), following BD PharMingen staining protocol. The data reflect gating on monocytes, based on forward and side scattered light signals. The quadrant markers for the bivariate dot plot were set based on autofluorescence controls (right panel).
本文来自投稿,不代表本人立场,如若转载,请注明出处:http://www.iamyjet.com/kangti/9794.html